Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

CPRXCPRX
31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in CATALYST PHARMACEUTICALS INC

GEODE CAPITAL MANAGEMENT, LLC holds 3.2M shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $99M as of 2026-Q2. The position was increased (+6.0% shares). CPRX represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$99M

Current Shares

3.2M

Total Value Change

+$94.9M

Total Shares Change

+1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.2M
+6.0%
$99M0.0%$31.43
32
2026-Q1
Increased
3M
+2.5%
$73.6M0.0%$23.92
30
2025-Q4
Increased
2.9M
+0.3%
$67.7M0.0%$23.29
30
2025-Q3
Increased
2.9M
+0.8%
$56.9M0.0%$19.55
30
2025-Q2
Increased
2.9M
+3.7%
$62.2M0.0%$21.78
31
2025-Q1
Increased
2.8M
+3.8%
$67.1M0.0%$24.69
31
2024-Q4
Increased
2.7M
+0.0%
$55.6M0.0%$21.07
29
2024-Q3
Decreased
2.7M
-1.3%
$53M0.0%$19.56
0
2024-Q2
Increased
2.7M
+7.6%
$41.8M0.0%$15.49
31
2024-Q1
Increased
2.5M
+14.0%
$40M0.0%$15.94
33
2023-Q4
Increased
2.2M
+5.5%
$37M0.0%$16.81
31
2023-Q3
Increased
2.1M
+8.3%
$24.4M0.0%$11.69
31
2023-Q2
Increased
1.9M
+3.9%
$25.9M0.0%$13.53
30
2023-Q1
Increased
1.9M
+5.2%
$30.7M0.0%$16.46
30
2022-Q4
Increased
1.8M
+4.5%
$32.8M0.0%$18.60
30
2022-Q3
Decreased
1.7M
-0.3%
$21.6M0.0%$12.70
0
2022-Q2
Decreased
1.7M
-3.5%
$11.9M0.0%$6.95
0
2022-Q1
Increased
1.8M
+1.4%
$14.5M0.0%$8.28
28
2021-Q4
Decreased
1.7M
-8.8%
$11.7M0.0%$6.89
0
2021-Q3
Increased
1.9M
+1.7%
$10.1M0.0%$5.02
28
2021-Q2
Increased
1.9M
+5.5%
$10.7M0.0%$5.78
29
2021-Q1
Increased
1.8M
+10.2%
$8.1M0.0%$4.34
30
2020-Q4
Increased
1.6M
+3.5%
$5.4M0.0%$3.42
28
2020-Q3
Decreased
1.5M
-1.7%
$4.6M0.0%$3.21
0
2020-Q2
Increased
1.6M
+2.1%
$7.3M0.0%$4.56
28
2020-Q1
Decreased
1.5M
-48.8%
$5.9M0.0%$3.88
0
2019-Q4
Increased
3M
+97.5%
$11.3M0.0%$3.67
45
2019-Q3
Increased
1.5M
+8.5%
$8.1M0.0%$5.27
30
2019-Q2
Increased
1.4M
+22.4%
$5.4M0.0%$3.84
33
2019-Q1
Decreased
1.1M
-46.1%
$5.8M0.0%$5.10
0
2018-Q4
New
2.1M
-
$4.1M0.0%$1.98
37

Other major holders of CPRX: BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used